GDF15 and atherosclerosis: Thus, GDF-15 appears to be a prognostic biomarker of CVD co-morbidity, but not a predictive biomarker of COPD outcomes, in agreement with recent findings suggesting that endothelial dysfunction predicts atherosclerosis in COPD, but does not contribute to airflow limitation [42].